ADDPI 2022_256 INADA vs Shivam Chaudhary

In November 2022 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the kabaddi player Shivam Chaudhary after his sample tested positive for the prohibited substance Metandienone.

Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Athlete denied the intentional use of the substance and could not explain the source of the prohibited substance.

The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation.
The Panel deems that the Athlete failed to demonstrate that the violation was not intentional, nor how the substance had entered his system.

Therefore the Panel decides on 8 April 2023 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 30 November 2022.

Original document


Legal Source
National Decisions
8 April 2023
Kumar, Akhil
Mahajan, Chaitanya
Medhi, Bikash
Original Source
India National Anti-Doping Agency (INADA)
Adverse Analytical Finding / presence
Kabaddi (IKF) - International Kabaddi Federation
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
New Delhi, India: National Dope Testing Laboratory
Doping classes
S1. Anabolic Agents
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Document type
Pdf file
Date generated
1 May 2023
Date of last modification
9 November 2023
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period